2012
Effect of Roux-en-Y gastric bypass on testosterone and prostate-specific antigen
Woodard G, Ahmed S, Podelski V, Hernandez-Boussard T, Presti J, Morton J. Effect of Roux-en-Y gastric bypass on testosterone and prostate-specific antigen. British Journal Of Surgery 2012, 99: 693-698. PMID: 22302466, DOI: 10.1002/bjs.8693.Peer-Reviewed Original ResearchConceptsProstate-specific antigenBody mass indexPSA levelsObese menGastric bypassSerum levelsWeight lossTestosterone levelsPSA massPercentage excess weight lossPlasma volumeExcess weight lossEffects of RouxSerum PSA levelsLow serum levelsSerum testosterone levelsConsecutive menMass indexSerum testosteroneProstate cancerMAIN OUTCOMETestosteroneDHEARYGBLongitudinal study
2011
Halo Effect for Bariatric Surgery: Collateral Weight Loss in Patients' Family Members
Woodard GA, Encarnacion B, Peraza J, Hernandez-Boussard T, Morton J. Halo Effect for Bariatric Surgery: Collateral Weight Loss in Patients' Family Members. JAMA Surgery 2011, 146: 1185-1190. PMID: 22006878, DOI: 10.1001/archsurg.2011.244.Peer-Reviewed Original ResearchConceptsGastric bypass surgeryBypass surgeryBody mass indexPatients' family membersAdult family membersHealthy behaviorsBariatric surgeryMass indexWeight lossLower body mass indexFamily membersMultidimensional health assessmentActivity levelsChildren of patientsSignificant weight lossDaily activity levelsQuality of lifeBariatric centerLifestyle counselingMorbid obesitySecondary outcomesWaist circumferenceObese childrenEffective treatmentUncontrollable eating
2010
One Year Improvements in Cardiovascular Risk Factors: a Comparative Trial of Laparoscopic Roux-en-Y Gastric Bypass vs. Adjustable Gastric Banding
Woodard GA, Peraza J, Bravo S, Toplosky L, Hernandez-Boussard T, Morton JM. One Year Improvements in Cardiovascular Risk Factors: a Comparative Trial of Laparoscopic Roux-en-Y Gastric Bypass vs. Adjustable Gastric Banding. Obesity Surgery 2010, 20: 578-582. PMID: 20186576, DOI: 10.1007/s11695-010-0088-0.Peer-Reviewed Original ResearchConceptsBiochemical cardiovascular risk factorsLaparoscopic adjustable gastric bandingAdjustable gastric bandingCardiovascular risk factorsTotal cholesterolRisk factorsGastric bandingGastric bypassHs-CRPLipoprotein cholesterolExcess weightHigh-sensitivity C-reactive proteinLow-density lipoprotein cholesterolSensitivity C-reactive proteinHigh-density lipoprotein cholesterolBackgroundCoronary artery diseaseConsecutive bariatric patientsPreventable risk factorsY Gastric BypassC-reactive proteinSingle academic institutionCause of deathSignificant weight lossPost-op valuesSignificant improvement
2009
Probiotics Improve Outcomes After Roux-en-Y Gastric Bypass Surgery: A Prospective Randomized Trial
Woodard GA, Encarnacion B, Downey JR, Peraza J, Chong K, Hernandez-Boussard T, Morton JM. Probiotics Improve Outcomes After Roux-en-Y Gastric Bypass Surgery: A Prospective Randomized Trial. Journal Of Gastrointestinal Surgery 2009, 13: 1198-1204. PMID: 19381735, DOI: 10.1007/s11605-009-0891-x.Peer-Reviewed Original ResearchMeSH KeywordsAdultBody Mass IndexConfidence IntervalsDose-Response Relationship, DrugDrug Administration ScheduleFemaleFollow-Up StudiesGastric BypassHumansMaleMiddle AgedObesity, MorbidPatient SatisfactionPostoperative CarePostoperative ComplicationsProbabilityProbioticsProspective StudiesReference ValuesRisk AssessmentTreatment OutcomeWeight LossConceptsGastric bypass surgeryBacterial overgrowthProbiotic groupControl groupWeight lossBypass surgeryGreater percent excess weight lossPercent excess weight lossY Gastric Bypass SurgeryExcess weight lossProspective randomized trialsVitamin B12 levelsMethodsForty-four patientsQuality of lifeEnduring treatmentGastric bypassMorbid obesityB12 levelsPostoperative changesResultsAt 6Randomized trialsVitamin B12 availabilityProbiotic administrationGastrointestinal floraGI microbiota